ABio materials Co., Ltd. Launches “Celexo AAPE,” a Multi-Care Hair Booster for the Scalp and Hair, Powered by Exosome and PDRN Technologies

Seoul, South Korea, October 8, 2026 -- Combining stem cell conditioned media, plant-derived exosomes, and olive-derived PDRN for continuous scalp care

Dual-vial system featuring freeze-dried powder and a solution ampoule designed to maximize the effectiveness of active ingredients

The global hair care market has recently been undergoing a major shift. Traditionally focused on cleansing the hair surface and improving damaged hair through shampoos and treatments, the market is now expanding into the area of “skincare-inspired scalp care,” which focuses on improving the scalp environment itself while addressing concerns related to hair loss and hair density.

As concerns over scalp conditions and hair loss increasingly affect younger consumers due to modern-day stress, environmental pollution, and lifestyle changes, consumer demand has grown significantly for comprehensive and continuous solutions that maintain both scalp condition and overall hair health, rather than temporary styling or one-time treatments.

As a result, the professional hair solution market—including scalp-specific ampoules, tonics, and products incorporating advanced biotechnology—is experiencing strong growth.

Against this backdrop, ABio materials Co., Ltd., a biotechnology materials specialist, has introduced a hair booster formulated with advanced bioactive ingredients, including human- and plant-derived exosomes and PDRN, as it looks to strengthen its position in an increasingly sophisticated scalp and hair care market.

ABio materials Co., Ltd. has launched “Celexo AAPE,” a new hair booster designed to provide comprehensive care for both the scalp and hair.

Celexo AAPE is designed to provide targeted scalp and hair care in response to recent market trends. Rather than focusing on a single ingredient or concern, the product incorporates a “continuous multi-care system” that takes into account scalp condition, hair density, hair thickness, and the overall environment for healthy hair.

The product consists of two vials per set: a freeze-dried powder (Step 1) and a solution ampoule (Step 2). The two formulations are stored separately according to the characteristics of their ingredients and are designed to be mixed immediately before use, helping maximize the effectiveness of the active ingredients.

The freeze-dried powder contains AAPE 3.1 (stem cell conditioned media), produced using ABio materials Co., Ltd.’ patented cultivation method, “Celtivation™ Technology.” Compared with conventional cell culture technology, AAPE 3.1 is characterized by its higher content of proteins and exosomes.

Celtivation™ Technology is ABio materials Co., Ltd.’ patented technology that applies Centella asiatica-derived exosomes during the stem cell cultivation process to enhance the culture environment and optimize the balance of beneficial components.

Based on its accumulated research expertise in stem cell conditioned media and exosomes, the company further developed its existing AAPE technology to create AAPE 3.1, which has been incorporated as a key ingredient in Celexo AAPE.

AAPE (Advanced Adipose-derived Stem Cells Protein Extracts) is a complex protein ingredient derived from human adipose-derived stem cell conditioned media. It has been studied as a material for scalp and hair care through numerous academic papers and related studies. Celexo AAPE builds upon this body of AAPE research by incorporating ABio materials Co., Ltd. proprietary cultivation technology.

The accompanying solution ampoule contains olive-derived PDRN, asparagus-derived exosomes, and Houttuynia cordata-derived exosomes. It is also formulated with ingredients selected with scalp and hair condition in mind, including caffeine, panthenol, biotin, and arginine.

Rather than simply combining individual ingredients, Celexo AAPE integrates them into a comprehensive care system designed around the close relationship between the scalp and hair. The system helps manage various aspects of scalp condition—including oil and moisture balance, the scalp barrier, and dead skin cells—while supporting an environment conducive to healthy, resilient hair.

The launch of Celexo AAPE is particularly significant in that, unlike conventional hair care products focused primarily on cleansing and basic nutrient supply, it combines advanced biotechnology—including stem cell conditioned media, human- and plant-derived exosomes, and PDRN—to introduce a new approach to bio-based scalp and hair care.

In particular, the combination of a dual-vial system designed to preserve the freshness of active ingredients, and exosome technology, an advanced bio-delivery platform, is expected to play an important role in the professional hair solution market, both among consumers seeking specialized scalp care and among clinics, medical institutions, and aesthetic professionals.

An ABio materials Co., Ltd. representative said, “Based on the stem cell conditioned media and exosome research technologies we have accumulated over the years, we will continue to introduce differentiated hair care solutions under the Celexo brand.”

The representative added, “We also plan to continue developing a diverse range of scalp and hair care products while expanding our presence in professional markets both in Korea and overseas.”

Contact Info:
Name: Chang yuju
Email: Send Email
Organization: ABio materials
Website: https://en.celexo.co.kr/

Release ID: 89205546

In case of identifying any errors, concerns, or inconsistencies within the content shared in this press release that necessitate action or if you require assistance with a press release takedown, we strongly urge you to notify us promptly by contacting [email protected] (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our expert team is committed to addressing your concerns within 8 hours by taking necessary actions diligently to rectify any identified issues or supporting you with the removal process. Delivering accurate and reliable information remains our top priority.